






















Bebida Beverage Company: Bebida Beverages' Strategic Adjustments for Water


🞛 This publication is a summary or evaluation of another publication
MOORESVILLE, NC--(Marketwire - May 13, 2009) - Bebida Beverages Company (
"The cost stranglehold that is created by the big companies has brought the profit margin down to an unsustainable level, therefore in an effort to continue in a profitable venture several strategic moves are going to happen. Piranha Water will now 'Take a Bite out of thirst' in a blue tinted 20oz bottle differentiating itself from all the others in 16.9 oz clear bottles and giving the consumer more bang for their buck," said Brian. After extensive research Piranha Water will now be available in purified water as well as spring water depending on region. Purified water and reverse osmosis seems to have an abundance of documentation to support the fact that it is actually better for consumption than spring water.
"With the constant rise and fall of shipping cost this will allow us to package in closer proximity to the majority of the largest retail distribution outlets," says Daisy Ramirez VP. Bebida Beverages.
"As we move forward, Piranha Water as a purified product opens up a whole group of municipal and government agencies that have a tremendous amount of consumtion as well as buying power. Our sales team will be aggressively seeking these outlets in the weeks to come," adds Daisy.
Bebida Beverages portfolio now consists of Piranha Water, Guppy Water, Koma Unwind, and Koma Unwind Shot.
Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.